Pekka Simula is the CEO of Herantis Pharma Plc (HRTIS:FN), a public drug development company based in Finland with focus on regenerative medicine based on leading science. Simula is also Chairman for Finnish Bioindustries. Simula has previously worked e.g. as founding CEO of Oncos Therapeutics, Project Director for CRF Health, and Global Program Manager at Varian Medical Systems (NYSE:VAR). He holds an MSc in physics.